Skip to main content
KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
17.30
+1.07 (6.59%)
At close: Mar 9, 2026, 4:00 PM EDT
17.31
+0.01 (0.08%)
After-hours: Mar 9, 2026, 7:19 PM EDT

KalVista Pharmaceuticals Revenue

KalVista Pharmaceuticals had revenue of $13.69M in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $1.43M.

Revenue (ttm)
$1.43M
Revenue Growth
n/a
P/S Ratio
613.22
Revenue / Employee
$5,281
Employees
270
Market Cap
874.45M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Apr 30, 2025---
Apr 30, 2024---
Apr 30, 2023---
Apr 30, 2022---
Apr 30, 2021---
Apr 30, 2020 Pro Pro Pro
Apr 30, 2019 Pro Pro Pro
Apr 30, 2018 Pro Pro Pro
Apr 30, 2017 Pro Pro Pro
Apr 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MannKind 348.97M
Phathom Pharmaceuticals 175.11M
Xencor 125.58M
CytomX Therapeutics 113.63M
Kura Oncology 67.48M
Evommune 13.00M
Janux Therapeutics 10.00M
Revenue Rankings

KALV News

More News